Oscar Health
OSCR
32.91
+0.57
+1.76%
Oscar Health
US · OSCR
#1512 by market cap
Listed 2021
32.91
+0.57
+1.76%
Live - 5344 symbols - heartbeat 275s ago
· 2026-10-08 07:35
Pre-market
32.61
-0.91%
After-hours
32.99
+0.24%
Overnight
32.70
-0.64%
- Market cap
- 10.16B
- P/E (TTM)i
- 25.32
- P/Bi
- 4.95
- EPSi
- -1.69
- Div yieldi
- 0.00%
- 52W posi
- 93%
Reader sentiment
Are you bullish or bearish on OSCR?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
38.00 +15.5%
Price target rangecurrent 32.91
Low30.00
Avg38.00
High49.00
Buy 43%
Hold 43%
Sell 14%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-23 | Piper Sandler | -- | BUY | 48.00 |
| 2026-09-22 | Raymond James | -- | BUY | -- |
| 2026-09-18 | Raymond James | -- | BUY | 42.00 |
| 2026-09-17 | Piper Sandler | -- | BUY | 48.00 |
| 2026-09-17 | BofA Securities | -- | SELL | 30.00 |
| 2026-09-17 | Baird | -- | HOLD | 33.00 |
| 2026-09-17 | Goldman Sachs | -- | HOLD | 34.00 |
| 2026-09-17 | Barclays | -- | BUY | 49.00 |
| 2026-08-07 | Baird | -- | HOLD | 27.00 |
| 2026-08-07 | Stephens | -- | HOLD | 34.00 |
| 2026-08-07 | Barclays | -- | BUY | 39.00 |
| 2026-08-06 | Barclays | -- | BUY | 39.00 |
| 2026-07-28 | Piper Sandler | -- | BUY | 36.00 |
| 2026-06-10 | Barclays | -- | BUY | 35.00 |
| 2026-06-09 | Barclays | -- | HOLD | 30.00 |
| 2026-05-26 | Barclays | -- | HOLD | 30.00 |
| 2026-05-11 | Goldman Sachs | -- | HOLD | 22.00 |
| 2026-05-07 | Wells Fargo | -- | SELL | 11.00 |
| 2026-05-07 | UBS | -- | HOLD | 20.00 |
| 2026-05-07 | BofA Securities | -- | SELL | 13.00 |
| 2026-05-07 | Barclays | -- | HOLD | 21.00 |
| 2026-04-20 | Jefferies | -- | HOLD | 16.00 |
| 2026-02-18 | Wells Fargo | -- | SELL | 11.00 |
| 2026-02-12 | Raymond James | -- | BUY | 18.00 |
| 2026-02-11 | UBS | -- | HOLD | 15.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
4
■ Upgrades■ Downgrades
- 4 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: Barclays moved from Hold to Buy on 2026-06-10.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-10 | Barclays | HOLD → BUY | 35.00 |
| 2026-04-20 | Jefferies | SELL → HOLD | 16.00 |
| 2026-01-09 | UBS | SELL → HOLD | 17.00 |
| 2026-01-05 | Barclays | SELL → HOLD | 18.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±10.96% | -11.86% (beat) |
| 2026/Q1 | 2026-05-06 | -- | ±10.53% | +10.59% (beat) |
| 2025/Q4 | 2026-02-10 | -- | ±12.49% | +1.74% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±9.95% | -2.76% (in line) |
| 2025/Q2 | 2025-08-06 | -- | ±11.58% | +3.76% (in line) |
| 2025/Q1 | 2025-05-07 | -- | ±18.13% | +30.22% (beat) |
| 2024/Q4 | 2025-02-04 | After close | ±20.74% | +3.08% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±18.62% | -12.28% (in line) |
| 2024/Q2 | 2024-08-07 | -- | ±15.86% | -3.08% (in line) |
| 2024/Q1 | 2024-05-07 | -- | ±16.08% | +4.22% (in line) |
| 2023/Q4 | 2024-02-07 | After close | ±16.40% | +24.38% (beat) |
| 2023/Q3 | 2023-11-07 | -- | ±17.86% | +15.94% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:35:11 · For reference only, not investment advice and not tailored to your situation.